vs
Floor & Decor Holdings, Inc.（FND）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Floor & Decor Holdings, Inc.的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 3.4%，领先31.0%），Royalty Pharma plc同比增速更快（4.8% vs -0.7%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 0.8%）
Floor & Decor Holdings, Inc.是美国多渠道专业零售企业，对外使用Floor & Decor品牌开展业务，创立于2000年，总部位于美国佐治亚州士麦那，主营各类硬质面地板及相关配套配件，线上线下销售渠道全面覆盖。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FND vs RPRX — 直观对比
营收规模更大
FND
是对方的1.9倍
$622.0M
营收增速更快
RPRX
高出5.5%
-0.7%
净利率更高
RPRX
高出31.0%
3.4%
两年增速更快
RPRX
近两年复合增速
0.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $39.7M | $214.2M |
| 毛利率 | 44.0% | — |
| 营业利润率 | 4.5% | 62.4% |
| 净利率 | 3.4% | 34.4% |
| 营收同比 | -0.7% | 4.8% |
| 净利润同比 | -18.8% | 2.9% |
| 每股收益（稀释后） | $0.37 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNDRPRX
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M |
净利润FNDRPRX
| Q1 26 | $39.7M | — | ||
| Q4 25 | $39.3M | $214.2M | ||
| Q3 25 | $57.3M | $288.2M | ||
| Q2 25 | $63.2M | $30.2M | ||
| Q1 25 | $48.9M | $238.3M | ||
| Q4 24 | $47.5M | $208.2M | ||
| Q3 24 | $51.7M | $544.0M | ||
| Q2 24 | $56.7M | $102.0M |
毛利率FNDRPRX
| Q1 26 | 44.0% | — | ||
| Q4 25 | 43.5% | — | ||
| Q3 25 | 43.4% | — | ||
| Q2 25 | 43.9% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 43.5% | — | ||
| Q2 24 | 43.3% | — |
营业利润率FNDRPRX
| Q1 26 | 4.5% | — | ||
| Q4 25 | 4.6% | 62.4% | ||
| Q3 25 | 6.1% | 70.1% | ||
| Q2 25 | 6.7% | 36.3% | ||
| Q1 25 | 5.5% | 94.0% | ||
| Q4 24 | 5.3% | 60.9% | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 6.3% | 50.2% |
净利率FNDRPRX
| Q1 26 | 3.4% | — | ||
| Q4 25 | 3.5% | 34.4% | ||
| Q3 25 | 4.9% | 47.3% | ||
| Q2 25 | 5.2% | 5.2% | ||
| Q1 25 | 4.2% | 41.9% | ||
| Q4 24 | 4.3% | 35.1% | ||
| Q3 24 | 4.6% | 96.3% | ||
| Q2 24 | 5.0% | 19.0% |
每股收益（稀释后）FNDRPRX
| Q1 26 | $0.37 | — | ||
| Q4 25 | $0.36 | $0.49 | ||
| Q3 25 | $0.53 | $0.67 | ||
| Q2 25 | $0.58 | $0.07 | ||
| Q1 25 | $0.45 | $0.55 | ||
| Q4 24 | $0.44 | $0.46 | ||
| Q3 24 | $0.48 | $1.21 | ||
| Q2 24 | $0.52 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $293.6M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.5B | $9.7B |
| 总资产 | $5.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FNDRPRX
| Q1 26 | $293.6M | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务FNDRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益FNDRPRX
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.4B | $9.7B | ||
| Q3 25 | $2.4B | $9.6B | ||
| Q2 25 | $2.3B | $9.5B | ||
| Q1 25 | $2.2B | $9.8B | ||
| Q4 24 | $2.2B | $10.3B | ||
| Q3 24 | $2.1B | $10.3B | ||
| Q2 24 | $2.0B | $9.8B |
总资产FNDRPRX
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.5B | $19.6B | ||
| Q3 25 | $5.5B | $19.3B | ||
| Q2 25 | $5.4B | $18.3B | ||
| Q1 25 | $5.4B | $17.6B | ||
| Q4 24 | $5.1B | $18.2B | ||
| Q3 24 | $4.9B | $18.0B | ||
| Q2 24 | $4.8B | $17.7B |
负债/权益比FNDRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $109.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.75× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FNDRPRX
| Q1 26 | $109.2M | — | ||
| Q4 25 | $124.1M | $827.1M | ||
| Q3 25 | $102.5M | $702.6M | ||
| Q2 25 | $84.1M | $364.0M | ||
| Q1 25 | $71.2M | $596.1M | ||
| Q4 24 | $101.4M | $742.5M | ||
| Q3 24 | $160.3M | $703.6M | ||
| Q2 24 | $194.0M | $658.2M |
自由现金流FNDRPRX
| Q1 26 | — | — | ||
| Q4 25 | $45.1M | — | ||
| Q3 25 | $24.5M | — | ||
| Q2 25 | $-10.0M | — | ||
| Q1 25 | $4.4M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $36.5M | — | ||
| Q2 24 | $80.0M | — |
自由现金流率FNDRPRX
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | -0.8% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 7.1% | — |
资本支出强度FNDRPRX
| Q1 26 | — | — | ||
| Q4 25 | 7.0% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 8.8% | — | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 10.1% | — |
现金转化率FNDRPRX
| Q1 26 | 2.75× | — | ||
| Q4 25 | 3.15× | 3.86× | ||
| Q3 25 | 1.79× | 2.44× | ||
| Q2 25 | 1.33× | 12.06× | ||
| Q1 25 | 1.46× | 2.50× | ||
| Q4 24 | 2.14× | 3.57× | ||
| Q3 24 | 3.10× | 1.29× | ||
| Q2 24 | 3.42× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FND
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
